Sientra gets FDA nod for its Portfinder technology; shares up

Project Sage Oldco

17/05/2023 14:29

** Shares of medical aesthetics firm Sientra Inc  SIEN.O 
jump 17.28% to $1.90, premarket
    ** U.S. Food and Drug Administration (FDA) grants marketing
clearance for company's Portfinder technology
    ** Portfinder is an electronic handheld device that will
allow clinicians to locate the right administration spot for 
tissue expansion with co's Dermaspan and AlloX2 Pro tissue
expanders
    ** A tissue expander is an empty implant used in
reconstruction surgeries 
    ** Over time tissue expander is gradually filled with saline
 to stretch the skin and cause it to grow and create a new
pocket for the long-term implants
    ** SIEN down about 20% YTD

 (Reporting by Vaibhav Sadhamta)
 ((Vaibhav.Sadhamta@thomsonreuters.com;))